The role of DNA damage in the resistance of human chronic myeloid leukemia cells to cyclophosphamide analogues
- PMID: 7923171
The role of DNA damage in the resistance of human chronic myeloid leukemia cells to cyclophosphamide analogues
Abstract
We examined 4-hydroperoxycyclophosphamide (4HC) and phosphorodiamidic mustard (PM)-mediated cytotoxicity and DNA interstrand cross-link (ISC) induction in a 4HC-resistant subline, B5-180(3), that was derived from the subcloned human myeloid leukemia cell line KBM-7/B5. Based on the ratio of the 50% inhibitory concentration values, B5-180(3) cells were approximately 35-fold resistant to 4HC compared with the parental cells. 4HC-induced ISC levels (as measured by alkaline elution) were approximately 9-fold lower in the 4HC-resistant line than the parent line. To determine whether the approximately 9-fold reduction of initial 4HC-induced ISCs was related to elevated aldehyde dehydrogenase (ADH), we examined PM-mediated cytotoxicity and ISC induction in the two cell lines. Unlike 4HC, the cytotoxicity of PM is independent of ADH activity. B5-180(3) cells were between 5- and 7-fold resistant to the cytotoxic effects of PM and were only slightly (approximately 1.3-fold) resistant to PM-mediated ISC induction. Furthermore, when cells were exposed to 4HC in the presence of 40 micrograms/ml cyanamide, an efficient inhibitor of ADH, the resistance index based on the 50% inhibitory concentration values was decreased to approximately 8. Elevated ADH can therefore explain most of the decrease in 4HC-induced ISCs, with elevated GSH levels probably accounting for the remaining small increment of resistance. Thus, decreased levels of ISC induction can account for a factor of approximately 9 of the total approximately 35-fold resistance to 4HC. The remaining increment of resistance to 4HC, as well as the cross-resistance to PM, appears to relate to an enhanced ability of the resistant subline to tolerate drug-induced ISCs. Thus, multiple factors appear to be involved in the resistance of these cells to the cytotoxic and DNA-damaging effects of 4HC, with elevated ADH and temporal factors (related to the processing of DNA damage) being the most important of these.
Similar articles
-
Mechanisms of cyclophosphamide resistance in a human myeloid leukemia cell line.Acta Oncol. 1995;34(2):247-51. doi: 10.3109/02841869509093963. Acta Oncol. 1995. PMID: 7718264
-
Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs.Cancer Chemother Pharmacol. 1996;38(5):406-16. doi: 10.1007/s002800050504. Cancer Chemother Pharmacol. 1996. PMID: 8765433
-
Enhanced expressions of glucose-6-phosphate dehydrogenase and cytosolic aldehyde dehydrogenase and elevation of reduced glutathione level in cyclophosphamide-resistant human leukemia cells.Blood Cells Mol Dis. 1998 Jun;24(2):231-8. doi: 10.1006/bcmd.1998.0188. Blood Cells Mol Dis. 1998. PMID: 9714700
-
Model studies of cyclophosphamide resistance in human myeloid leukemia.Cancer Treat Res. 2002;112:211-35. doi: 10.1007/978-1-4615-1173-1_11. Cancer Treat Res. 2002. PMID: 12487104 Review. No abstract available.
-
Cellular mechanisms of cyclophosphamide resistance: model studies in human medulloblastoma cell lines.Cancer Treat Res. 2002;112:199-209. doi: 10.1007/978-1-4615-1173-1_10. Cancer Treat Res. 2002. PMID: 12481718 Review. No abstract available.
Cited by
-
Altered gene expression in busulfan-resistant human myeloid leukemia.Leuk Res. 2008 Nov;32(11):1684-97. doi: 10.1016/j.leukres.2008.01.016. Epub 2008 Mar 12. Leuk Res. 2008. PMID: 18339423 Free PMC article.
-
Metabolism and pharmacokinetics of oxazaphosphorines.Clin Pharmacokinet. 2000 Apr;38(4):291-304. doi: 10.2165/00003088-200038040-00001. Clin Pharmacokinet. 2000. PMID: 10803453 Review.
-
Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer.Br J Cancer. 2016 Jan 19;114(2):177-87. doi: 10.1038/bjc.2015.398. Epub 2015 Dec 22. Br J Cancer. 2016. PMID: 26695443 Free PMC article.
-
SIRT1 as a potential key regulator for mediating apoptosis in oropharyngeal cancer using cyclophosphamide and all-trans retinoic acid.Sci Rep. 2024 Jan 2;14(1):41. doi: 10.1038/s41598-023-50478-6. Sci Rep. 2024. PMID: 38167952 Free PMC article.
-
Drug resistance and DNA repair in leukaemia.Cytotechnology. 1998 Sep;27(1-3):175-85. doi: 10.1023/A:1008064804678. Cytotechnology. 1998. PMID: 19002791 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical